Connor Clark & Lunn Investment Management Ltd. Increases Holdings in Utah Medical Products, Inc. (NASDAQ:UTMD)

Connor Clark & Lunn Investment Management Ltd. boosted its position in shares of Utah Medical Products, Inc. (NASDAQ:UTMD) by 72.1% during the 3rd quarter, HoldingsChannel reports. The firm owned 10,337 shares of the medical instruments supplier’s stock after buying an additional 4,330 shares during the period. Connor Clark & Lunn Investment Management Ltd.’s holdings in Utah Medical Products were worth $692,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also bought and sold shares of UTMD. Brandes Investment Partners LP grew its position in shares of Utah Medical Products by 66.2% during the 2nd quarter. Brandes Investment Partners LP now owns 116,524 shares of the medical instruments supplier’s stock worth $7,789,000 after buying an additional 46,427 shares in the last quarter. Minerva Advisors LLC grew its holdings in Utah Medical Products by 461.8% during the 3rd quarter. Minerva Advisors LLC now owns 42,328 shares of the medical instruments supplier’s stock worth $2,818,000 after acquiring an additional 34,794 shares in the last quarter. Los Angeles Capital Management LLC grew its holdings in Utah Medical Products by 154.3% during the 2nd quarter. Los Angeles Capital Management LLC now owns 33,283 shares of the medical instruments supplier’s stock worth $2,224,000 after acquiring an additional 20,197 shares in the last quarter. Rice Hall James & Associates LLC increased its position in Utah Medical Products by 24.3% during the 3rd quarter. Rice Hall James & Associates LLC now owns 83,338 shares of the medical instruments supplier’s stock valued at $5,576,000 after purchasing an additional 16,297 shares during the period. Finally, Bank of Montreal Can bought a new stake in shares of Utah Medical Products in the 2nd quarter valued at about $1,039,000. 69.60% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Separately, StockNews.com downgraded shares of Utah Medical Products from a “strong-buy” rating to a “buy” rating in a research note on Thursday, November 7th.

Utah Medical Products Trading Down 0.0 %

UTMD opened at $65.15 on Friday. The firm has a market cap of $220.99 million, a price-to-earnings ratio of 15.26 and a beta of 0.08. Utah Medical Products, Inc. has a 12 month low of $63.38 and a 12 month high of $87.21. The stock has a fifty day moving average price of $65.72 and a 200-day moving average price of $67.13.

Utah Medical Products Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, January 3rd. Shareholders of record on Monday, December 16th will be issued a $0.305 dividend. The ex-dividend date of this dividend is Monday, December 16th. This is an increase from Utah Medical Products’s previous quarterly dividend of $0.30. This represents a $1.22 dividend on an annualized basis and a yield of 1.87%. Utah Medical Products’s payout ratio is currently 28.57%.

Utah Medical Products Company Profile

Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.